Author

K. Esser-Nobis

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Assay:protein structure· 1 Assay:proteomics· 1

Frequent Co-Authors

M. Gale· 2 shared T.-Y. Hsiang· 2 shared A. Chen· 1 shared A. E. L. Stone· 1 shared A. Forero· 1 shared A. Josephson-Day· 1 shared A. M. Kell· 1 shared A. Pong· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. Gale

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivPreprintNov 7, 2022

Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation

O. Colasanti, R. Burm, H.-E. Huang…·V. Lohmann

This study compares HAV and HCV infections in vivo and in vitro, revealing that HAV induces an innate immune response via MDA5/LGP2 with limited protease-mediated suppression, while HCV activates TLR3 without TRIF cleavage.

DOI 10.1101/2022.11.07.515428

humanexperimental assay

𝕏 PostBluesky

ImmunologybioRxivApr 21, 2021

Endomembrane targeting of human OAS1 p46 augments antiviral activity

F. W. Soveg, J. Schwerk, N. S. Gokhale…·R. Savan

This study shows that the OAS1 p46 isoform, targeted to the endomembrane system, enhances antiviral activity against RNA viruses and is associated with COVID-19 severity.

DOI 10.7554/elife.71047

humanproteomics

𝕏 PostBluesky

BiochemistrybioRxivAug 3, 2020

De novo design of ACE2 protein decoys to neutralize SARS-CoV-2

T. W. Linsky, R. Vergara, N. Codina…·D.-A. Silva

The paper designs de novo ACE2 protein decoys to neutralize SARS-CoV-2 by blocking viral entry, showing high affinity and potent in vitro inhibition.

DOI 10.1126/science.abe0075

humanprotein structure

𝕏 PostBluesky